LLY

916.01

+1.44%↑

JNJ

237.11

+0.7%↑

ABBV

206.87

+1.29%↑

NVS

147.2

+0.9%↑

AZN

184.04

+0.37%↑

LLY

916.01

+1.44%↑

JNJ

237.11

+0.7%↑

ABBV

206.87

+1.29%↑

NVS

147.2

+0.9%↑

AZN

184.04

+0.37%↑

LLY

916.01

+1.44%↑

JNJ

237.11

+0.7%↑

ABBV

206.87

+1.29%↑

NVS

147.2

+0.9%↑

AZN

184.04

+0.37%↑

LLY

916.01

+1.44%↑

JNJ

237.11

+0.7%↑

ABBV

206.87

+1.29%↑

NVS

147.2

+0.9%↑

AZN

184.04

+0.37%↑

LLY

916.01

+1.44%↑

JNJ

237.11

+0.7%↑

ABBV

206.87

+1.29%↑

NVS

147.2

+0.9%↑

AZN

184.04

+0.37%↑

Search

Integra LifeSciences Holdings Corp

Fermé

SecteurSoins de santé

8.89 -0.11

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.85

Max

8.96

Chiffres clés

By Trading Economics

Revenu

3.7M

-1.7M

Ventes

33M

435M

Marge bénéficiaire

-0.392

Employés

4,427

EBITDA

12M

66M

Recommandations

By TipRanks

Recommandations

Vente

Prévisions sur 12 Mois

+25.84% upside

Dividendes

By Dow Jones

Prochains Résultats

4 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-214M

702M

Ouverture précédente

9

Clôture précédente

8.89

Sentiment de l'Actualité

By Acuity

100%

0%

329 / 350 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

Integra LifeSciences Holdings Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

22 mars 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

22 mars 2026, 23:50 UTC

Market Talk

LG Electronics Set to Stage Strong Earnings Rebound in 1Q -- Market Talk

22 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Lower on Prospects of Liquidity-Driven Sales -- Market Talk

22 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Nikkei May Fall as Concerns About Middle East Conflict Persist -- Market Talk

22 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Global Forex and Fixed Income Roundup: Market Talk

22 mars 2026, 23:41 UTC

Market Talk
Principaux Événements d'Actualité

Oil Edges Lower as Traders Eye Trump's Deadline to Reopen Strait of Hormuz -- Market Talk

22 mars 2026, 22:57 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Location of Aurum's Discoveries Present Potential Future Synergies

22 mars 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Aurum Share Acquisition Cost A$23.69 Million

22 mars 2026, 22:56 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Aurum's Boundiali Gold Project Located to South of Sissingue Gold Mine

22 mars 2026, 22:55 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Participated in Aurum Resources Equity Raising

22 mars 2026, 22:54 UTC

Acquisitions, Fusions, Rachats

Perseus Mining: Acquires 9.9% Interest in Aurum Resources

22 mars 2026, 22:22 UTC

Market Talk
Principaux Événements d'Actualité

After Selloff, Gold Seen Supported by Strait of Hormuz Deadline -- Market Talk

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Synopsys Has Market Value Over $80 Billion; Major Customers Include Nvidia -- WSJ

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Activist Elliott Builds Big Stake in Chip-Design Software Maker Synopsys -- WSJ

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Activist Elliott Investment Management Has Multibillion-Dollar Investment in Synopsys, Sources Say -- WSJ

22 mars 2026, 22:06 UTC

Acquisitions, Fusions, Rachats

Elliott Plans to Push Synopsys to Make More Money From Its Software and Services, Sources Say -- WSJ

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International Plans 59.2 Tons of Gold Production in 2026; up 12.3% on Year >2259.HK

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International Rising Gold Prices Supported Results >2259.HK

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International 2025 Rev $5.38B Vs. $2.99B >2259.HK

22 mars 2026, 21:53 UTC

Résultats

Zijin Gold International 2025 Net $1.60B Vs. Net $481.37M >2259.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical Plans CNY131.6B-CNY148.6B Capex Spending in 2026>0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical: Decrease in Sales Volumes of Refined Oil Products Also Hurt Results >0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical 2025 Results Weighed by Decrease in Prices of Petroleum, Petrochemical Products>0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical 2025 Rev CNY2.78T Vs. CNY3.07T >0386.HK

22 mars 2026, 21:31 UTC

Résultats

China Petroleum & Chemical 2025 Net CNY32.48B Vs. Net CNY48.94B >0386.HK

22 mars 2026, 21:25 UTC

Market Talk
Principaux Événements d'Actualité

Bonds Decoupling From Oil Amid Longer Conflict Fears -- Market Talk

22 mars 2026, 21:22 UTC

Acquisitions, Fusions, Rachats

St Barbara: Remarks Follow Recent Inquiries About Simberi's Fuel Stocks

22 mars 2026, 21:21 UTC

Acquisitions, Fusions, Rachats

St Barbara: Simberi Currently Uses About 65,000 Liters Per Day For Mining Fleet, Power Generation

22 mars 2026, 21:21 UTC

Market Talk

Revised Fuel Subsidy Mechanism Positive for Ampol, Viva Energy -- Market Talk

22 mars 2026, 21:21 UTC

Acquisitions, Fusions, Rachats

St Barbara: Has Been Taking Precaution to Increase Diesel Storage For Several Months

Comparaison

Variation de prix

Integra LifeSciences Holdings Corp prévision

Objectif de Prix

By TipRanks

25.84% hausse

Prévisions sur 12 Mois

Moyen 11.25 USD  25.84%

Haut 13 USD

Bas 9 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Vente

5 ratings

0

Achat

3

Maintien

2

Vente

Score Technique

By Trading Central

12.75 / 16.41Support & Résistance

Court Terme

Strong Bearish Evidence

Moyen Terme

Strong Bearish Evidence

Long Terme

Weak Bearish Evidence

Sentiment

By Acuity

329 / 350Classement par Soins de santé

Sentiment de l'Actualité

Très Fortes Indications Baissières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Inférieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
help-icon Live chat